Treatment with glibenclamide in maturity-onset diabetes mellitus.
D000367:Age Factors; D000368:Aged; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003927:Diet, Diabetic; D005260:Female; D005905:Glyburide / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D014044:Tolbutamide / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D005905:Glyburide